Fundraising FoxCentrus Diagnostics
Issaquah, US · Founded 2022 · Delaware corporation
Find your way into Centrus Diagnostics
Sign up to see every warm intro you have to Centrus Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Centrus Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Centrus Diagnostics develops CentrusDx Smart Bands, wearable sensor wristbands using photoplethysmography (PPG) to provide continuous, cuffless blood pressure and EKG measurements for patients, caregivers, and health-conscious consumers. The devices target the diagnosis and management of hypertension, heart failure, and atrial fibrillation, and are pending FDA 510(k) clearance in the U.S. and CDSCO approval in India.
Founders & leadership
Board
Funding
SEC filings, press & company announcements$1.7M disclosed across 1 of 2 rounds · 2024–2025
- Undisclosed amountSeries A1Jun 2025Source ↗
▶$1.7MraisedJun 2025 · 13 investors · Other Health CareRule 506(b)
- Michael CoyleDirector
- Michael BurnamExecutive Officer, Director
- Srikanth JadcheriaExecutive Officer, Director
- Offering amount
- $1.7M
- Amount sold
- $1.7M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Centrus Diagnostics.
Frequently asked questions
- What does Centrus Diagnostics do?
- Centrus Diagnostics develops CentrusDx Smart Bands, wearable sensor wristbands using photoplethysmography (PPG) to provide continuous, cuffless blood pressure and EKG measurements for patients, caregivers, and health-conscious consumers. The devices target the diagnosis and management of hypertension, heart failure, and atrial fibrillation, and are pending FDA 510(k) clearance in the U.S. and CDSCO approval in India.
- How much funding has Centrus Diagnostics raised?
- Centrus Diagnostics has disclosed $1.7M raised across 1 of its 2 known rounds.
- Where is Centrus Diagnostics headquartered?
- Centrus Diagnostics is headquartered in Issaquah, US.